ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $308,000 | 0.0% | 2,985 | -10.0% | 0.12% | +8.3% |
Q2 2022 | $308,000 | -20.8% | 3,315 | 0.0% | 0.11% | -10.7% |
Q1 2022 | $389,000 | -19.0% | 3,315 | -7.0% | 0.12% | -3.2% |
Q4 2021 | $480,000 | -1.4% | 3,566 | +16.7% | 0.12% | -6.0% |
Q3 2021 | $487,000 | +15.7% | 3,056 | -4.5% | 0.13% | +11.8% |
Q2 2021 | $421,000 | +16.9% | 3,200 | +14.7% | 0.12% | +7.2% |
Q1 2021 | $360,000 | -20.4% | 2,790 | +3.0% | 0.11% | -21.8% |
Q4 2020 | $452,000 | +10.2% | 2,710 | +1.9% | 0.14% | -5.3% |
Q3 2020 | $410,000 | +13.3% | 2,660 | +8.6% | 0.15% | +4.9% |
Q2 2020 | $362,000 | – | 2,450 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |